Legal Representation
Attorney
Mark J. Zimmermann
USPTO Deadlines
Next Deadline
432 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-10-06)
Due Date
October 06, 2026
Grace Period Ends
April 06, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 6, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jul 21, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 21, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 1, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 18, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 18, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 18, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 18, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 18, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 7, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 7, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 7, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 6, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 4, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 042
Full service optical laboratories that design spectacle frames and lens
First Use Anywhere:
May 1, 2001
First Use in Commerce:
May 1, 2001
Class 044
Optometry services, namely, providing comprehensive eye exams in the nature of refractions to evaluate for glasses and contact lens prescriptions, and glasses for computer eye strain; Medical evaluations and treatment for glaucoma, red eye, allergies, eye pain, diabetes and high blood pressure, cataract evaluation; medical Lasik consultations and co-management in the nature of medical monitoring of patient recovery from ocular surgical procedures; dry eye medical evaluations and treatment
First Use Anywhere:
May 1, 2001
First Use in Commerce:
May 1, 2001
Additional Information
Pseudo Mark
DALLAS EYE WORKS
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DALLAS"